Related Experiment Video
Updated: May 9, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Hepatitis C virus screening and management of seroconversions in hemodialysis facilities
Chukwuma Mbaeyi1, Nicola D Thompson
1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA. cmbaeyi@cdc.gov
Insights
Hepatitis C virus (HCV) transmission in hemodialysis facilities is a serious concern. Routine screening for HCV antibodies and strict adherence to infection control are crucial for prevention.
Area of Science:
- Infectious Diseases
- Public Health
- Nephrology
Background:
- Healthcare-associated hepatitis C virus (HCV) transmission is a significant issue in hemodialysis settings.
- HCV prevalence is notably higher in hemodialysis patients, leading to increased morbidity and mortality.
- Outbreaks between 2008-2011 highlighted failures in infection control and screening protocols.
Purpose of the Study:
- To emphasize the critical need for compliance with national guidelines for HCV antibody (anti-HCV) screening in hemodialysis patients.
- To outline essential actions for managing potential HCV transmission within hemodialysis facilities.
- To reinforce infection control practices as key to preventing HCV spread in these units.
Main Methods:
- Review of national guidelines for anti-HCV screening on admission and semiannually for susceptible patients.
- Emphasis on early detection through routine screening and timely notification of new infections to public health officials.
- Assessment of facility-level infection control practices, including medication handling, hand hygiene, and disinfection.
Main Results:
- HCV outbreaks have occurred due to infection control breaches in hemodialysis facilities.
- Non-compliance with screening and response guidelines contributes to HCV transmission.
- Effective management requires routine screening, patient notification, and robust infection control.
Conclusions:
- Routine anti-HCV screening and strict adherence to infection control are paramount for preventing HCV transmission in hemodialysis units.
- Early detection and prompt management of new HCV infections are essential.
- No vaccine exists, making screening and infection control the primary preventive strategies.
Abstract:
Over the past two decades, healthcare-associated exposure has increasingly been proved to be a means of hepatitis C virus (HCV) transmission, especially in hemodialysis facilities. The prevalence of HCV among hemodialysis patients is known to be several times greater than that of the general population of the United States, and chronic HCV infection is associated with significant morbidity and mortality among these patients. During 2008-2011, HCV infection outbreaks were identified in multiple US hemodialysis facilities, resulting in at least 46 new HCV infections among hemodialysis patients. These outbreaks, linked to infection control breaches, also highlight the failure of some facilities to follow established guidelines for routine HCV antibody (anti-HCV) screening and response to new HCV infection among hemodialysis patients. Current national guidelines recommend screening of hemodialysis patients for anti-HCV on facility admission and, for susceptible patients, on a semiannual basis. Here, we seek to underscore the importance of compliance with national recommendations for anti-HCV screening of hemodialysis patients and actions to be taken in the event of possible HCV transmission within a hemodialysis facility. These include general steps to ensure that: hemodialysis patients are routinely screened for anti-HCV to facilitate early detection of new infections; newly infected patients are informed of the change in their HCV status and undergo clinical evaluation; and public health officials are notified of new HCV infections in a timely manner. We then focus on the need to assess infection control practices at the facility, with particular attention given to safe handling of injectable medications, hand hygiene and disinfection practices. In the absence of a vaccine, routine screening and adherence to standard infection control practices will remain the key strategies for preventing HCV transmission in hemodialysis units.
Related Concept Videos
Hemodialysis III: Nursing Management
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hepatitis
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
